Skip to main content
OpenTrials

Clinical trial condition

Brain Diseases, Metabolic

Explore clinical trials studying Brain Diseases, Metabolic. Study availability and eligibility vary by location and protocol.

1,102 public trials 225 recruiting studies
Refine in advanced search Browse all conditions

Brain Diseases, Metabolic trial results

Active, Not Recruiting

ZIP Study-OL Study of Safety, PK, Efficacy, PD, Immunogenicity of ATB200/AT2221 in Pediatrics Aged 0 to < 18 y.o. w/LOPD

NCT03911505

Conditions
Brain Diseases, Brain Diseases, Metabolic, Brain Diseases, Metabolic, Inborn, +13 more
Locations
  • University of Florida Clinical Research Center Gainesville, Florida, United States
  • Wolfson Children's Hospital Jacksonville, Florida, United States
  • Woodruff Memorial Research Building Atlanta, Georgia, United States
  • St. Louis Children's Hospital St Louis, Missouri, United States
View all 17 locations
View Trial Details
Active, Not Recruiting

A Phase 1/Phase 2 Open-label Study to Evaluate the Safety, Tolerability, and Efficacy of a Single Intravenous Administration of SAR444836 in Adult Participants With Phenylketonuria

NCT05972629

Conditions
Amino Acid Metabolism, Inborn Errors, Brain Diseases, Brain Diseases, Metabolic, +10 more
Locations
  • University of California San Francisco- Site Number : 8400007 San Francisco, California, United States
  • Children's Hospital IMD Clinic- Site Number : 8400015 Aurora, Colorado, United States
  • University of Florida-Genetics- Site Number : 8400010 Gainesville, Florida, United States
  • UHCMC- Site Number : 8400014 Cleveland, Ohio, United States
View Trial Details
Active, Not Recruiting

Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With Cirrhosis

NCT05297448

Conditions
Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +8 more
Locations
  • Bausch Site 591 Homewood, Alabama, United States
  • Bausch Site 445 Chandler, Arizona, United States
  • Bausch Site 453 Sun City, Arizona, United States
  • Bausch Site 587 Tucson, Arizona, United States
View all 188 locations
View Trial Details
Active, Not Recruiting

Study to Assess Rifaximin Soluble Solid Dispersion (SSD) for the Delay of Encephalopathy Decompensation in Cirrhosis

NCT05071716

Conditions
Brain Diseases, Brain Diseases, Metabolic, Central Nervous System Diseases, +8 more
Locations
  • Bausch Site 182 Dothan, Alabama, United States
  • Bausch Site 129 Chandler, Arizona, United States
  • Bausch Site 103 Peoria, Arizona, United States
  • Bausch Site 180 Phoenix, Arizona, United States
View all 150 locations
View Trial Details

Related conditions